Inhaled Aviptadil Is a New Hope for Recovery of Lung Damage due to COVID-19 - Esendagli, Dorina; Sarı, Nuran; Akhan, Sıla; Arslan, Sonay; Doğan Öntaş, İrem Asena; Yılmaz, Gürdal; Aksoy, Firdevs; Kant, Aydın; Yaşar, Kadriye Kart; Ünlü, Esra Canbolat; Akıllı, Işıl Kibar; Çelen, Mustafa Kemal; et al. (Medical principles and practice, 2025)
Keywords: Administration, Inhalation; Adult; Aged; Clinical trials; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Drug dosages; Dyspnea; Female; Hospitalization; Humans; Infections; Intensive care; Male; Medical imaging; Middle Aged; Patients; Peptides; Performance evaluation; Pneumonia; Prospective Studies; Regulatory approval; Respiratory failure; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Standard of care; Vital signs; COVID-19; SARS-CoV-2; Aviptadil; Inhalation; Lung injury